01952 EVEREST MED
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 2.54X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 2.1% | Net Margin | N/A |
Total Debt/Equity | 13.5% | Return on Equity | N/A |
Price/Book | 5.37X | Return on Assets | N/A |
(HKD 71.300) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -1,107.50 | -930.77 | -277.25 | -1,233.76 | -6,715.11 |
---|---|---|---|---|---|
Net Profit Growth (%) | -19.0 | -235.7 | +77.5 | +81.6 | -2,700.3 |
Earnings Per Share (HKD) | -3.451 | -2.973 | -0.932 | -4.207 | -78.677 |
Earnings Per Share Growth (%) | -16.1 | -219.2 | +77.9 | +94.7 | +99.2 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 13.266 | 16.918 | 20.314 | 24.141 | 27.689 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 706.678 | 125.932 | +461.2 | 12.792 |
Operating Result | -1,041 | -843.033 | +23.5 | -1,567 |
Profit Before Taxation | -1,041 | -844.463 | +23.3 | -247.275 |
Taxation | 0 | 0 | N/A | 0.008 |
Profit /( Loss) After Taxation | -1,041 | -844.463 | +23.3 | -247.283 |
Net Profit | -1,041 | -844.463 | +23.3 | -247.283 |
Earnings Per Share () | -3.4510 | -2.9731 | +16.1 | -0.9315 |
Announcement Date | 2025-03-26 | 2024-03-28 | NA | 2023-03-31 |
* Annualised
Last Update Time: 2025-07-22 21:40:25